
Ceftamide M 200mg/1000mg Injection
Marketer
Health Biotech Limited
Salt Composition
Mesna (200mg) + Ifosfamide (1000mg)
Overview Ceftamide M 200mg/1000mg Injection
Ceftamide M 200mg/1000mg Injection, a dual-action prescription medication for cancer treatment, inhibits cancer cell proliferation and aids in tumor regression. Administration is strictly under medical supervision; self-injection is strongly discouraged. Report any allergies to this medication to your physician immediately. Potential side effects include nausea, vomiting, alopecia, anemia, and leukopenia. Pre- and during-treatment blood tests may be required to monitor blood cell counts. Supplementation may be recommended to mitigate medication-induced deficiencies; a diet rich in fruits and vegetables is also encouraged. Disclose all other medications, pregnancy, breastfeeding, and existing health conditions to your doctor. Alcohol consumption should be avoided during treatment. Refrain from operating vehicles or heavy machinery while using this medication.
Primary Ingredients of Ceftamide M 200mg/1000mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ceftamide M 200mg/1000mg Injection
Malignancy
Major Benefits of Ceftamide M 200mg/1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftamide M 200mg/1000mg Injection:
- Hair loss
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Blood in urine
- Decreased white blood cell count
- Increased risk of infection
- Neurotoxicity
How to use Ceftamide M 200mg/1000mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ceftamide M 200mg/1000mg Injection works:
Ceftamide M Injection (200mg/1000mg) unites Ifosfamide, a cancer treatment, with Mesna, a protective agent. Ifosfamide targets cancerous DNA, hindering cellular growth and reproduction. Mesna's inclusion mitigates the potential for Ifosfamide-induced bladder complications, such as hematuria and edema.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption with Ceftamide M 200mg/1000mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Ceftamide M 200mg/1000mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use necessary if the potential benefits outweigh the acknowledged hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Lactation is contraindicated for patients using Ceftamide M 200mg/1000mg Injection due to potential infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingUNSAFE
Administering Ceftamide M 200mg/1000mg Injection may induce adverse reactions that can impair driving capabilities.
KidneyCAUTION
Administering Ceftamide M 200mg/1000mg Injection requires careful consideration in individuals suffering from renal impairment. Dosage modification of Ceftamide M 200mg/1000mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Ceftamide M 200mg/1000mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ceftamide M 200mg/1000mg Injection :
Omit a Ceftamide M 200mg/1000mg Injection dose? Seek medical advice immediately.
Facts to Know About Ceftamide M 200mg/1000mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
